Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 442.40
Bid: 441.40
Ask: 442.40
Change: -7.00 (-1.56%)
Spread: 1.00 (0.227%)
Open: 450.60
High: 450.60
Low: 436.80
Prev. Close: 449.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Aug 2015 10:00

RNS Number : 5057V
QinetiQ Group plc
10 August 2015
 



QinetiQ Group plc

 

10 August 2015

 

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES OR THEIR CONNECTED PERSONS

 

Vesting of Award under the QinetiQ Group plc 2012 Performance Share Plan

The Company announces that on 10 August 2015 the following Executive Director acquired Ordinary Shares of 1p each ('Shares'), as detailed in the table below, as a result of the vesting of part of an award granted on 9 August 2012 under the QinetiQ Group plc 2012 Performance Share Plan ('PSP'):

Director

Number of Shares acquired on vesting under the PSP Award on 10 August 2015

% of Issued Share Capital

David Mellors

65,860

0.01%

 

The balance of the 2012 PSP award granted to Mr Mellors did not meet the performance targets and has lapsed.

The PSP operates as follows:

Vesting of awards granted under the PSP occurs three years after the award date, subject to the achievement of the following performance conditions:

(i) 50% of an award is subject to an Earnings per Share target set over a three year performance period; and

(ii) 50% of an award is subject to Total Shareholder Return measured over a three year performance period.

No exercise price is applicable for the awards.

As a result of the above transaction, the aggregate number of Shares held beneficially by the Executive Director (across all accounts) is as follows:

Director

Resulting aggregate number of Shares held beneficially (across all accounts)

Total percentage holding following notification

David Mellors

491,769

0.08%

 

This notification is made pursuant to rule 3.1.4R of the FCA Disclosure Rules and Transparency Rules.

END

 

For further information:

 

Jon Messent, Company Secretary, QinetiQ Group plc

 

David Bishop, Investor Relations, QinetiQ Group plc

 

01252 392000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSAFIWFISELA
Date   Source Headline
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.